OPtilume™ BPH Catheter SystEm for Treatment of Men eXperiencing Symptomatic BPH

NCT06560476 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2026-03-27

No results posted yet for this study

Summary

APEX is a prospective multi-site registry of real-world experience with the Optilume™ BPH Catheter System for treatment of men experiencing symptomatic BPH.

Conditions

  • Benign Prostatic Hyperplasia

Interventions

OTHER

Data collection

Subject's data will be collected from patients that are undergoing care using the Optilume drug-coated catheter system.

Sponsors & Collaborators

  • Urotronic Inc.

    lead INDUSTRY

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-30
Primary Completion
2027-03-30
Completion
2027-03-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06560476 on ClinicalTrials.gov